Annual report pursuant to Section 13 and 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.24.1
Description of Business and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash Following is a summary of cash, cash equivalents and restricted cash at December 31, 2023 and December 31, 2022:
(in thousands)   December 31,
2023		     December 31,
2022		  
Cash and cash equivalents   $ 76,677     $ 108,910  
Restricted cash – current    
-
       396  
Restricted cash – long-term     313       302  
Cash, cash equivalents and restricted cash   $ 76,990     $ 109,608  
Schedule of Computation of Diluted Net Loss Per Share For the years ended December 31, 2023 and 2022, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units and warrants, have not been included in the computation of diluted net loss per share as the result would have been anti-dilutive.
(in thousands)   December 31,
2023		     December 31,
2022		  
Stock Options     5,445       3,396  
Restricted Stock Units     305       325  
Warrants     1,442       1,443  
Total     7,192       5,164